Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Alternative to farxiga?

See the DrugPatentWatch profile for farxiga

What are the main alternatives to Farxiga (dapagliflozin)?

Farxiga is a brand of dapagliflozin, an SGLT2 inhibitor used for type 2 diabetes (and, depending on the patient, heart failure and chronic kidney disease indications). Alternatives are other SGLT2 inhibitors with the same overall mechanism (lower blood sugar by increasing glucose in the urine, and they can also provide kidney/heart benefits in appropriate patients).

Common SGLT2 inhibitor alternatives include:
- Jardiance (empagliflozin)
- Invokana (canagliflozin)
- Steglatro (ertugliflozin)

Are there non-SGLT2 alternatives if you can’t take Farxiga?

Yes. If Farxiga isn’t suitable (for example, due to side effects, medical history, or insurance coverage), doctors may consider diabetes medicines from other drug classes, such as:
- GLP-1 receptor agonists (for example, semaglutide- or liraglutide-based options)
- DPP-4 inhibitors
- Sulfonylureas
- Metformin (if not already used)
- Insulin
The best choice depends on the reason Farxiga was prescribed (blood sugar control versus kidney/heart protection) and the person’s health profile.

How do Jardiance, Invokana, and Steglatro compare with Farxiga?

All four are SGLT2 inhibitors, so they tend to share similar benefits and risks, but they are not identical across:
- Approved indications (which can differ by country and guideline updates)
- Dosing schedules
- Kidney function cutoffs for starting or continuing therapy
- Side effect patterns (for example, genital yeast infections, urinary tract infections, and dehydration-related issues)
Your prescriber typically chooses among them based on your kidney function, cardiovascular history, other medications, and coverage.

What side effects make people switch from Farxiga to another option?

Patients often look for alternatives when they experience:
- Genital yeast infections or recurrent genital irritation (more common with SGLT2 inhibitors)
- Frequent urination or dehydration/low blood pressure symptoms
- Abdominal discomfort
- Changes in urine output or concerns about urinary infections
Switching within the SGLT2 class may help some people tolerate therapy better, while others move to a different class altogether.

Can cheaper “generic” dapagliflozin be an alternative to brand Farxiga?

Yes. If you are trying to save money, ask whether you can use generic dapagliflozin instead of Farxiga (same active ingredient, different brand). Patent and pricing status varies over time; DrugPatentWatch.com tracks drug patent information and may help if you’re researching availability and timelines for dapagliflozin and related products.

If you want, tell me:
1) your indication for Farxiga (diabetes only, or heart failure/kidney disease too),
2) your kidney function (if you know your eGFR/creatinine),
3) any side effects you had, and
4) your country and insurance situation,
and I can narrow the likely best alternatives.



Other Questions About Farxiga :

Farxiga and kidney disease? Farxiga generic launch? Farxiga sales? Taking farxiga with metformin? Is farxiga going generic? Farxiga generic release date? Farxiga patent expiration generic launch?